| Budget Amount *help |
¥25,350,000 (Direct Cost: ¥19,500,000、Indirect Cost: ¥5,850,000)
Fiscal Year 2021: ¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2020: ¥5,850,000 (Direct Cost: ¥4,500,000、Indirect Cost: ¥1,350,000)
Fiscal Year 2019: ¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2018: ¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2017: ¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
|
|---|
| Outline of Final Research Achievements |
The ever-evolving performance of computers and improvements in computational software contribute to the advancement of the mathematical sciences, where computation is essential. However, dramatic future developments in computation will depend on the dramatic evolution of algebraic computation. Algebraic and numerical computation have advantages and disadvantages in terms of efficiency and accuracy. The key to the success of research is to integrate the advantages of both. Currently, experts in numerical computation disregard algebraic computation as impractical, while experts in algebraic computation are more concerned with the theoretical aspects and lack collaborative work. This challenging research pioneered an original fusion theory between novel algebraic computation and existing numerical computation, and challenged the creation of a mathematical model to predict the probability of adverse drug reactions of drug candidate compounds.
|
